Analyst Price Targets — CVRX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 11:53 am | William Plovanic | Canaccord Genuity | $10.00 | $5.69 | TheFly | CVRx price target lowered to $10 from $11 at Canaccord |
| November 6, 2025 1:45 pm | Ross Osborn | Cantor Fitzgerald | $13.00 | $9.98 | TheFly | CVRx price target raised to $13 from $11 at Cantor Fitzgerald |
| October 30, 2024 7:55 am | Matt O'Brien | Piper Sandler | $16.00 | $12.90 | StreetInsider | CVRx Inc (CVRX) PT Raised to $16 at Piper Sandler |
| September 10, 2024 7:48 am | Ross Osborn | Cantor Fitzgerald | $14.00 | $7.96 | TheFly | Cantor starts CVRx with Overweight on heart failure potential |
| July 30, 2024 6:51 am | Matt O'Brien | Piper Sandler | $13.00 | $9.27 | TheFly | CVRx price target lowered to $13 from $15 at Piper Sandler |
| July 30, 2024 6:27 am | William Plovanic | Canaccord Genuity | $15.00 | $9.27 | StreetInsider | CVRx Inc (CVRX) PT Raised to $15 at Canaccord Genuity |
| July 11, 2024 8:41 am | Frank Takkinen | Lake Street | $12.00 | $7.59 | TheFly | CVRx price target lowered to $12 from $18 at Lake Street |
| June 5, 2024 9:07 am | Frank Takkinen | Loop Capital Markets | $18.00 | $8.00 | StreetInsider | CVRx Inc (CVRX) PT Lowered to $18 at Lake Street Capital Markets |
| May 1, 2024 6:57 am | Chase Knickerbocker | Craig-Hallum | $23.00 | $9.27 | StreetInsider | Craig-Hallum Assumes CVRx Inc (CVRX) at Buy |
Latest News for CVRX
LOS ANGELES, April 09, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises CVRx , Inc , (“ CVRx " or the "Company") ( NASDAQ : CVRX ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Orthofix Medical (NASDAQ: OFIX - Get Free Report) and CVRx (NASDAQ: CVRX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Volatility and Risk Orthofix Medical has a beta
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CVRX, INC. (CVRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER…
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CVRX, INC. (CVRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On…
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CVRX, INC. (CVRX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CVRX.
U.S. House Trading
No House trades found for CVRX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.